13F

Stock

TScan Therapeutics, Inc.

TCRX · held by 1 managers

Reported value

$85.4K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$102.7K

Price effect on 1 books still in the name

Largest holder

$85.4K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC61.9K$85.4K−$102.7KCut−$119.9K

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.